Literature DB >> 11813879

Angiogenesis in the central nervous system: a role for vascular endothelial growth factor/vascular permeability factor and tenascin-C. Common molecular effectors in cerebral neoplastic and non-neoplastic "angiogenic diseases".

D Zagzag1, V Capo.   

Abstract

Human pathological conditions of the central nervous system (CNS) associated with angiogenesis (i.e. neovascularization) include neoplastic, as well as infectious, ischemic, and traumatic processes. Upregulation of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) and tenascin-C (TN-C) is spatially and temporally related to neovascularization. Spatially, VEGF/VPF and TN-C are both found at the site of neovascularization, but they are not detected in areas of normal brain or in areas without neovascularization. Temporally, VEGF/VPF and TN-C are found at the peak of angiogenesis and are not detected when angiogenesis had ceased.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11813879     DOI: 10.14670/HH-17.301

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  11 in total

Review 1.  Changes in laminin isoforms associated with brain tumor invasion and angiogenesis.

Authors:  Julia Y Ljubimova; Manabu Fujita; Natalya M Khazenzon; Alexander V Ljubimov; Keith L Black
Journal:  Front Biosci       Date:  2006-01-01

Review 2.  Molecular mechanisms of glioma cell migration and invasion.

Authors:  Tim Demuth; Michael E Berens
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

3.  Distribution pattern of tenascin-C in glioblastoma: correlation with angiogenesis and tumor cell proliferation.

Authors:  Senija Behrem; Kamelija Zarković; Neven Eskinja; Nives Jonjić
Journal:  Pathol Oncol Res       Date:  2005-12-31       Impact factor: 3.201

4.  Brevican, neurocan, tenascin-C and versican are mainly responsible for the invasiveness of low-grade astrocytoma.

Authors:  Imre Varga; Gábor Hutóczki; Csaba D Szemcsák; Gábor Zahuczky; Judit Tóth; Zsolt Adamecz; Annamária Kenyeres; László Bognár; Zoltán Hanzély; Almos Klekner
Journal:  Pathol Oncol Res       Date:  2011-10-14       Impact factor: 3.201

5.  Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis.

Authors:  A Calvo; R Catena; M S Noble; D Carbott; I Gil-Bazo; O Gonzalez-Moreno; J-I Huh; R Sharp; T-H Qiu; M R Anver; G Merlino; R B Dickson; M D Johnson; J E Green
Journal:  Oncogene       Date:  2008-05-26       Impact factor: 9.867

6.  Novel antitenascin antibody with increased tumour localisation for Pretargeted Antibody-Guided RadioImmunoTherapy (PAGRIT).

Authors:  R De Santis; A M Anastasi; V D'Alessio; A Pelliccia; C Albertoni; A Rosi; B Leoni; R Lindstedt; F Petronzelli; M Dani; A Verdoliva; A Ippolito; N Campanile; V Manfredi; A Esposito; G Cassani; M Chinol; G Paganelli; P Carminati
Journal:  Br J Cancer       Date:  2003-04-07       Impact factor: 7.640

7.  Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy.

Authors:  Giuseppe Gritti; Andrea Gianatti; Fiorella Petronzelli; Rita De Santis; Chiara Pavoni; Riccardo Lorenzo Rossi; Laura Cattaneo; Luigi Giusto Spagnoli; Silvia Ferrari; Andrea Rossi; Anna Maria Barbui; Alessandro Rambaldi
Journal:  Oncotarget       Date:  2018-01-03

8.  The role of tenascin-C in tissue injury and tumorigenesis.

Authors:  Kim S Midwood; Gertraud Orend
Journal:  J Cell Commun Signal       Date:  2009-10-17       Impact factor: 5.782

9.  Update and developments in the treatment of glioblastoma multiforme - focus on bevacizumab.

Authors:  Naveed Wagle; Leia Nghiemphu; Albert Lai; Whitney Pope; Paul S Mischel; Timothy Cloughesy
Journal:  Pharmgenomics Pers Med       Date:  2010-06-09

10.  Does Tenascin have Clinical Implications in Pathological Grade of Glioma Patients?: A Systematic Meta-Analysis.

Authors:  Xiangyi Kong; Wenbin Ma; Yongning Li; Yu Wang; Jian Guan; Jun Gao; Junji Wei; Yong Yao; Wei Lian; Zhiqin Xu; Wanchen Dou; Bing Xing; Zuyuan Ren; Changbao Su; Yi Yang; Renzhi Wang
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.